Indonesia to Launch Bio Farma's COVID-19 Vaccine

By Editorial Team 03/08/2022
Ilustrasi Vaksin Merah Putih
Summary

The Indonesian government will launch a COVID-19 vaccine in collaboration with PT Bio Farma and United States-based Baylor College of Medicine on August 17, 2022. Bio Farma President Director Honesti Basyir said the "State-Owned Enterprises [SOE] vaccine" is undergoing phase III clinical trials run by the Food and Drug Monitoring Agency (BPOM).

Bio Farma has submitted an emergency use authorization (EUA) to BPOM and completed an audit submission to verify the halal status to the Indonesian Ulema Council (MUI). "The president has prepared a special name for the SOE COVID-19 vaccine, and Bio Farma is registering the name with the Directorate General of Intellectual Property Rights of the Ministry of Law and Human Rights," Honesti said Monday.

Register now and get free access.

If you want to get free access to our Daily Insights and Weekly Digest, please click "Sign up" button below. If you already have an account, please login.

Sign up
Log in
What do subscribers receive?

As a subscriber, you'll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Register now and get free access, click here to register. Feel free to contact us with any additional questions you have.